Status: current, Primitive. Date: 31-Jan 2004. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2150835018 | Efalizumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 2158639014 | Efalizumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Efalizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Efalizumab | Is a | Immunosuppressant | true | Inferred relationship | Some | ||
| Efalizumab | Is a | Monoclonal antibody agent | false | Inferred relationship | Some | ||
| Efalizumab | Has disposition | Immunomodulator | true | Inferred relationship | Some | ||
| Efalizumab | Is a | Murine-human monoclonal IgG antibody | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Efalizumab only product | Has active ingredient | True | Efalizumab | Inferred relationship | Some | 1 |
| Efalizumab-containing product | Has active ingredient | True | Efalizumab | Inferred relationship | Some | 1 |
| Raptiva | Has active ingredient | False | Efalizumab | Inferred relationship | Some | |
| Efalizumab 125mg/vial lyophilised powder for injection | Has active ingredient | False | Efalizumab | Inferred relationship | Some | |
| Raptiva 125mg/vial lyophilised powder for injection | Has active ingredient | False | Efalizumab | Inferred relationship | Some |
Reference Sets
Adverse reaction agent reference set
Substance foundation reference set
FHIR